Start a Decentralized (Virtual) CRO

1. 1

   Design the decentralized trial model

   A decentralized or virtual CRO replaces physical site visits with telemedicine, remote patient monitoring, eConsent, and home health visits. Decide how much of the trial you run remotely versus hybrid, and for which study types it fits, because not every protocol can be fully decentralized. The model's promise is lower dropout and wider patient access, which is what you are selling to sponsors.

2. 2

   Build or license the technology stack

   This model runs on a technology backbone: telehealth, eConsent, EDC, remote monitoring devices, and connected data systems, most of it licensed from upstream eClinical and digital-health vendors rather than built in-house. The stack must be validated and integrated so data flows cleanly and defensibly. Technology leverage is where a thin-margin CRO model can find scale.

3. 3

   Assemble the home-health and virtual-visit network

   Bringing the trial to the patient requires mobile nurses, home-health providers, and local phlebotomy or imaging partners across your geographies. Build and manage that network so a participant anywhere can complete visits reliably. Coverage and reliability of this network determine whether the decentralized promise actually holds up in practice.

4. 4

   Meet regulatory standards for remote conduct

   Decentralized trials still operate under GCP, FDA and EMA oversight, and IRB review, with added scrutiny on remote consent, data integrity, and patient safety at a distance. Your processes for eConsent, remote source data, and safety monitoring must be inspection-ready. Regulators increasingly accept decentralized elements, but only when the controls are rigorous and documented.

5. 5

   Win studies where access is the problem

   Your strongest pitch is to sponsors running rare-disease, geographically dispersed, or high-dropout studies where traditional sites cannot enroll or retain enough patients. Sell reduced dropout, faster enrollment, and access to patients no single site can reach. Deliver on those metrics and let each study prove the model for the next sponsor.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: Clinical and digital-health operators comfortable running trials without physical sites

Not for: Not for anyone who assumes technology removes the regulatory bar; decentralized trials carry the same GCP standard with extra scrutiny. Not for teams without both clinical-operations and digital-health capability, because the model sits squarely at that intersection.